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Abstract  
Cervical cancer is one of leading causes of cancer death in women in the developing 
countries. The use of cisplatin as chemotherapy agent in cervical cancer is known to cause side 
effects and also resistance for long-term uses. One of the strategies to prevent cervical cancer 
based on combination agents is being developed. Leunca (Solanum nigrum L.) has been revealed 
to inhibit growth of human cancer cells. Therefore, it can be used in combination with cisplatin 
to reduce those side effects and prevent the occurrence of cell resistance. Ethanolic extract of 
Leunca Herb (ELH) and cisplatin were tested their cytotoxic effect on HeLa cervical cancer cell 
by using MTT assay to determine IC50 value. The combinationss of cisplatin-ELH were tested 
to determine the combination index (CI value). The IC50 of ELH and cisplatin on HeLa cells 
were 227 µg/mL and 17 µM. rRespectively. Tthe study of combination resulted that almost all 
the index combinations were <0,9 showed the effect of synergism combination. The 
Ooptimum concentration of combination was 1/8 IC50 cisplatin–1/8 IC50 ELH. The results 
indicated that ELH had a potency to be combination agent to enhance the activity of cisplatin 
on HeLa cervical cancer cells. Therefore, further study on its molecular mechanism needs to 
be explored. 
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INTRODUCTION 
 
Cervical cancer remains to be the one of 
the greatest killers of women in the worldwide. 
Cisplatin as the chemotherapy in cervical cancer 
gave side effects like nephrotoxicity, 
neurotoxicity, ototoxicity, nausea, vomiting and 
resistant (Cepeda et al., 2007; Fuertes et al., 2003). 
The use of herbal medicines in combination with 
chemotherapy is one of the better ways in the 
treatment of advanced cancer cases because it can 
improve efficacy and reduce toxicity (Liu et al., 
2006)  Therefore, the research about  alternative 
cancer therapy using herbal extract as combination 
with chemotherapy is important to be developed.  
Leunca (Solanum nigrum L.) is the plant 
that has anticancer activity. The previous in vitro 
studies showed that β-2-solamargine on Leunca  
had cytotoxic effect on tumor cell lines HT-29 
(colon), HCT-15 (colon), LNCaP (prostate), PC-3 
(prostate), T47D (breast), and MDA-MB-231 
(breast) (Hu et al., 1999). The other studies, 
proved that solamargine could modulate the 
expressions of TNFRs and Bcl-2 on H441, H520, 
H661 and H69 human lung cancer cells (Liu et al., 
2004). Then solanine, a steroid alkaloid isolated 
from Leunca was known inducing apoptosis in 
HepG(2) cells seems to be mediated by the 
inhibition of Bcl-2 expression (Ji et al., 2008).  
The researches above revealed that Leunca had a 
potency to be anti-cancer agent. This study aims to 
explore the cytotoxic effect of Leunca and its 
influence in combination with Cisplatin on HeLa 
cervical cancer cells.  
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METHODS 
 
Ethanolic Extract of Leunca Herb 
(ELH). Leunca herb dried powder was harvested 
and determinated by Balai Besar Penelitian dan 
Pengembangan Tanaman Obat dan Obat 
Tradisional (B2P2TOOT), Tawangmangu, Central 
of Java. Then the herbs were extracted with 
maceration method by using ethanol 70% (1:10). 
Cell culture. HeLa cell line was 
obtained from Prof. Tatsuo Takeya (Nara Institute 
of Science and Technology, Japan) and grown in 
Dulbecco’s modified Eagle’s medium (DMEM; 
Gibco) supplemented with 10% fetal bovine serum 
(FBS; Gibco) and 1% 
v
/v  Penisilin-Streptomisin 
(Gibco) at temperature 37 °C and with a flow of 
5% CO2. 
Cytotoxic assay with MTT 
method. HeLa was planted in 96-well plates 
with 5x10
3
 cells/well and divided into control and 
treatment group. Final concentrations of ELH were 
1, 5, 10, 25, 50, 100 and 250 µg/mL. 10 mg of 
ELH was dissolved in dimethyl sulfoxide (DMSO) 
then diluted in culture medium until final 
concentrations. Concentrations of Cisplatin were 1, 
2, 5, 10, 20, 30 and 50 µM. After 24 h incubation, 
culture medium was removed and cells were 
washed using PBS (Sigma). 5 mg/mL of MTT on 
PBS (Sigma) was diluted by DMEM (1:10) and 
100 µl of it was added into each well. After 
incubate for 3 hours the reaction was stopped by 
Sodium Dodecyl Sulfate (SDS) 10% in HCL 0,1 
N. After that, the plate was incubated for one night 
in room condition at dark place. To make sure the 
formazan dissolve, the plate was shaked for 10 
minutes and measured the absorbance using 
ELISA reader at wave length of 595 nm. The 
concentration applied on combination 
chemotherapy of ELH was referred to IC50 value 
of each compound. The final combination 
concentrations of ELH  were 30, 60, 90 and 120 
µg/mL, and for cisplatin concentration were 2, 4, 6 
and 8 µM. 
Statatistical analysis and data 
interpretation. Absorbances measured from 
cytotoxic assay were analyzed by Excell MS 
Office and semi-log analysis (SPSS 11.5) to obtain 
IC50 value (Doyle and Griffiths, 2000). The 
Combination Index/CI (table I)  was calculated 
based on equation below :  
 
 
 
Note: 
D1 : combination concentration of for ELH 
D2 : combination concentration for of Cisplatin 
Dx1 : concentration of ELH in single dose that could 
inhibit the HeLa cells growth at the same point with 
combination concentration 
Dx2 : concentration of Cisplatin in single dose that could 
inhibit the HeLa cells growth at the same point with 
combination concentration (Reynolds and Maurer, 2005). 
 
 
Table 1. Interpretation of CI Values 
 
CI Value Interpretation 
< 0,1 very strong synergistic effect 
0,1 - 0,3 strong synergistic effect 
0,3 - 0,7 synergistic effect 
0,7 - 0,9 moderate  synergistic effect 
0,9 - 1,1 nearly additive effect 
1,1 - 1,45 moderate antagonist effect 
1,45 – 3,3 antagonist effect 
>3,3 very strong antagoni effect st 
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RESULTS  
 
Cytotoxic effect of Leunca Herb etanolic 
extract on HeLa cells.  The result showed that 
ELH has cytotoxic effect on HeLa cells with IC50 
value ofwas 227 µg/ml (Figure 1A) while for 
cisplatin has the IC50 value was of 17 µM (Figure 
1B).This IC50 value showed that ELH has the 
potency to inhibit HeLa cells growth. Therefore, 
Leunca could be used as a combination agent for 
cervical cancer treatment. 
 
 
 
 
                                           (A)                                                                 (B) 
 
Figure 1. The cytotoxic effect of HeLa cells. Treatment of ELH (A) and cisplatin (B) The data were 
obtained by MTT assay with the incubation of cells for 24 h at temperature of 37°C and flow of 
5% CO2. Each dot represent the means + SD from 3 replication. 
 
 
 
The Combination effect of Leunca Herb 
etanolic extract and cisplatin on HeLa 
cells.  
Despite its success, cisplatin has several 
disadvantages, like side effects and also the 
occurrence of resistance. Therefore, the 
combination of chemotherapeutic agent and herb 
extract expected to increase the chemotherapeutic 
agent activity and also inhibit the occurrence of 
resistance. 
The parameter of combination effect was CI 
value,which used to assess the degree of 
combination effect in each concentration of 
combination. The combination of ELH–cisplatin 
gave synergistic effect because almost all the CI 
value were under 0,9 (Fig 2&3, table 2). The 
combination of ELH-cisplatin that gave the biggest 
synergistic effect consisted of 30 µg/mL ELH - 2 
µM cisplatin and 90 µg/mL ELH - 2 µM cisplatin. 
This combination gave CI value of 0,58. The 
viability data showed that the combination of 
ELH-cisplatin (120 μg/ml-8 µM) inhibited the 
growth of HeLa cells until 46 %. This was higher 
than result given by single dose of each agent on 
the same concentration. 
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Figure 2. Combination effect of ELH-cisplatin on HeLa cells morphology. The picture was obtained by MTT 
assay with the incubation of cells for 24 h at temperature of 37°C and a flow of 5% CO2. (A) cell 
control ; (B) ELH 250 µg/mL; (C) ciplatin 8 µM; and (D) 120 µg/mL ELH- 2 µM ciplatin. Normal 
HeLa cells (                ) and morphological changes of cells   (                    ) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The CI values of ELH-cisplatin combination on HeLa cells. The data were obtained by MTT assay 
with the incubation of cells for 24 h at temperature of 37°C and with a flow of 5% CO2. 
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Table II. CI values of ELH-cisplatin combination. The bolds indicate CI value < 0,9 that have synergistic 
effect. The data was obtained by MTT assay. 
 
Cisplatin (µM) 
Leunca Herb Extract (µg/mL) 
30 60 90 120 
2 0,58 0,64 0,58 0,68 
4 0,86 0,67 0,70 0,74 
6 0,90 0,84 0,78 0,82 
8 0,91 0,92 0,86 0,89 
 
 
DISCUSSION  
 
This study showed that ELH has cytotoxic 
activity and a synergistic effect in low 
concentration combination with cisplatin against 
HeLa cervical cancer cells. The mechanism of 
cancer cell growth inhibition occurs through many 
pathways such as apoptosis. Apoptosis is the 
process of programmed cell suicide in the normal 
condition, it’s done to repair the broken tissues 
(Hanahan et al., 2000).  Apoptosis occurs by the 
down-regulation of anti-apoptotic proteins such as 
Bcl-2. Based on the previous studies, Leunca 
contains Solanine and β-Solamargine that able to 
decrease the expression of protein Bcl-2 (Liu et al., 
2004; Ji et al., 2008). Expression of Bcl-2 protein 
as an antiapoptosis protein can prevent cell death 
via apoptosis. Therefore its decreased expression 
could induce the cancer cells death (Pandanilam, 
2003). In addition, Solamargine or Solanine could 
influence the upstream of the Bcl-2, then inhibits 
the transcription of Bcl-2 protein. Finally, 
apoptosis can occur. Our study proved that ELH 
increased the cytotoxic activity of cisplatin on 
HeLa cervical cancer cells. Therefore, study about 
molecular mechanism of active compound found 
in Leunca Herb ethanolic extract that induce the 
cisplatin cytotoxic activity needs to be explored. 
 
CONCLUSION  
 
The conclusion of this study showed that 
combination between ELH and cisplatin gave 
synergistic effect on HeLa and induced the 
cytotoxic activity of cisplatin on HeLa cervical 
cancer cell. 
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